Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

Which prenatal biomarker is most appropriate for methylmercury dose-response for neurodevelopmental effects?

On this page:

  • Overview
  • Downloads
Developmental neurotoxicity (DNT) is a well-established hazard of methylmercury (MeHg) exposure. This evidence base primarily includes studies that measured biomarkers of MeHg exposure in samples of maternal hair, maternal blood, and cord blood. We used a comprehensive literature review (1998-2022) to investigate which of these prenatal biomarkers is more appropriate for detecting neurodevelopmental effects of MeHg.  Seven studies were identified that measured both maternal hair and cord blood Hg levels. In these studies, several DNT test results covering most domains of DNT were modeled. Cord blood Hg was found to produce larger effect estimates than maternal hair Hg across most domains of DNT with cord blood Hg being more sensitive in more than 90% of cases.  When comparing sensitivity of results from cord blood Hg to from maternal hair Hg there was a 75% increase (range: 4-583%). In the two domains where results for maternal hair Hg were more sensitive, the increase was only 18% (Range: 7-29%). There were only two studies that compared maternal blood with maternal hair biomarkers (maternal blood Hg was more sensitive (mean 320% and range 43-855%) and cord blood biomarkers (maternal blood Hg was more sensitive by about 30%).  Maternal hair Hg remains an appropriate biomarker for population exposure monitoring purposes, but these data suggest that cord blood Hg is more appropriate for modeling of MeHg DNT effects. Future work may benefit from simultaneous collection of MeHg content of maternal blood, hair and cord blood biomarker samples and using all of them for DNT modeling.

Impact/Purpose

The aim of this study was to assess which biomarker of exposure is more sensitive for risks of DNT effects of MeHg, using data from investigations that collected more than one biomarker in the same population to facilitate direct comparison.

Citation

Kopylev, L., M. Dzierlenga, Yu-Sheng Lin, Becky Nachman, E. Radke-Farabaugh, H. Ru, AND D. Segal. Which prenatal biomarker is most appropriate for methylmercury dose-response for neurodevelopmental effects? Blackwell Publishing, Malden, MA1-10, (2024). [DOI: 10.1080/10937404.2024.2444650]

Download(s)

  • https://www.tandfonline.com/doi/full/10.1080/10937404.2024.2444650#abstract
DOI: Which prenatal biomarker is most appropriate for methylmercury dose-response for neurodevelopmental effects?
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on January 29, 2025
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.